baber/WOPTO huggingface dataset:
Patent EP-0737763-B1 (EP)
Inventor: BAK HENNING
IPC: D03D15/50
Filed: 1996-03-29
Granted: 2000-12-27
Abstract: Hybrid yarn comprises: (A) reinforcing filaments with: (i) an initial modulus of more than 600 (800-25,000, pref. 2000-20,000) cN/tex; (ii) a max. tensile strength of more than 60 (80-220, pref. 100-200) cN/tex; (iii) a max. elongation of 0.01-20 (0.1-7.0 pref. 1-5) %; and (iv) a degree of crimping of 5-60 (12-50, pref. 18-36) %; and (B) thermoplastic matrix filaments with a m.pt. at least 10 (20-100, pref. 30-70) degrees C below the m.pt. of (A). Also claimed are: (i) permanently ductile textile sheet contg. an amt. of hybrid yarn sufficient to have a significant effect on the ductility of the sheet; (ii) fibre-reinforced mouldings; (iii) a process for the prodn. of hybrid yarn from components (A) and (B) in a swirling or blow-texturing system in which at least (A) is introduced with an overfeed of 5-60%; (iv) a process for the prodn. of textile sheet as above (i) by weaving, knitting, laying or matting; and (v) a process for the prodn. of mouldings as above (ii) by forming textile sheet (i) at a temp. above the m.pt. of (B) and below the m.pt. of (A).
Patent EP-0813803-B1 (EP)
Inventor: RIEKEN RALF
IPC: H05K7/14
Filed: 1996-02-19
Granted: 1998-08-12
Abstract: The invention concerns a device including an insulating support plate with conducting surfaces between bus bars, the suppport plate projecting beyond the bus bars in the transverse direction and filter condensors connected to the conducting surfaces being mounted on the projecting part.
Patent EP-0782460-B1 (EP)
Inventor: CHEN CHI
IPC: A61B5/145
Filed: 1996-04-17
Granted: 2003-11-12
Abstract: There is disclosed a method and apparatus for automatically conducting peritoneal equilibration testing. The method involves removing a sample of overnight dwell fluid from a patient in an amount sufficient to determine the concentration of a metabolite in the drain fluid. The concentration of the metabolite in the sample is then detected and the overnight dwell fluid is drained and weighed. A known weight of dialysate fluid is instilled into a patient and thereafter there are periodically withdrawn samples of the dialysate fluid and the concentration of metabolite in each sample is determined. The ratio of metabolite concentration of each of the periodically drawn samples to metabolite concentration for the overnight dwell fluid is determined. The patient is then drained after a predetermined dwell time and the volume of drained dialysate is determined. The mass transfer area coefficient of the patient's peritoneal membrane is then obtained as a function of the measured variables. Means are provided for conducting the method for each of the steps described.
Patent EP-0836380-B1 (EP)
Inventor: YAYON AVNER
IPC: A61K39/00
Filed: 1996-06-12
Granted: 2002-02-27
Abstract: The present invention concerns fibroblast growth factor receptor 3 (FGFR3) as a novel marker for mesenchymal skeletal progenitor cells. By utilizing this novel marker it was possible both to identify and locate mesenchymal skeletal progenitor cells in a tissue, as well as to obtain a substantially pure culture of such cells. The pure culture of the mesenchymal skeletal progenitor cells may be used, optionally after various manipulations ex vivo, as an active ingredient in pharmaceutical compositions or implants for the purpose of bone and/or cartilage repair. FGFR3 may also be used as a marker for the identification and the localization of cartilage- and bone-derived tumors. Agents capable of binding to FGFR3 may also be used for targeting cytotoxic agents to cartillage- and bone-derived tumors.The present invention concerns fibroblast growth factor receptor 3 (FGFR3) as a novel marker for mesenchymal skeletal progenitor cells. By utilizing this novel marker it was possible both to identify and locate mesenchymal skeletal progenitor cells in a tissue, as well as to obtain a substantially pure culture of such cells. The pure culture of the mesenchymal skeletal progenitor cells may be used, optionally after various manipulations ex vivo, as an active ingredient in pharmaceutical compositions or implants for the purpose of bone and/or cartilage repair. FGFR3 may also be used as a marker for the identification and the localization of cartilage- and bone-derived tumors. Agents capable of binding to FGFR3 may also be used for targeting cytotoxic agents to cartillage- and bone-derived tumors.
Patent EP-0830682-B1 (EP)
Inventor: SCHAEFER SCOTT
IPC: G11C11/409
Filed: 1996-06-04
Granted: 2001-08-29
Abstract: A synchronous dynamic random access memory (SDRAM) includes a memory array and is responsive to command signals and address bits. A command decoder/controller responds to selected command signals to initiate, at different times, a precharge command, an active command, and a transfer command. The command decoder/controller initiates the active command during the precharge command. Indicating circuitry responds to the precharge command to provide a precharge complete signal indicating the completion of a precharge command operation. A row address latch responds to the active command to receive and hold a value representing a row address of the memory array as indicated by the address bits provided at the time the active command is initiated, and responds to the precharge complete signal to release the row address.
Patent EP-0859830-B1 (EP)
Inventor: HALBERSTADT CRAIG
IPC: A61K35/12
Filed: 1996-09-23
Granted: 2003-12-03
Abstract: A method of increasing the number of adult pancreatic islet cells available for transplantation by contacting the cells with laminin 5 extracellular matrix. When contacted with the deposited matrix produced by 804G rat bladder carcinoma cells, a 1,500 fold increase in cell number is observed after three passages in culture. Islet cell expansion also occurs when cells are contacted with 804G soluble matrix. The expanded islet cells contain insulin and respond to glucose challenge.
Patent EP-0814783-B1 (EP)
Inventor: LUNDBERG PER JOHAN
IPC: A61K31/44
Filed: 1996-12-20
Granted: 2003-10-08
Abstract: Nouvelle forme galénique effervescente en comprimés et à unités multiples, contenant un inhibiteur de la pompe à protons, sensible à l'acide et se présentant sous la forme du racémate, d'un sel alcalin de celui-ci ou d'un de ses énantiomères propres ou d'un sel alcalin de ceux-ci, et les éléments constitutifs d'un comprimé effervescent. L'inhibiteur de la pompe à protons est de préférence de l'oméprazole ou un sel alcalin de celui-ci, ou du S-oméprazole ou un sel alcalin de celui-ci. De plus, l'invention concerne un procédé de fabrication de ladite formulation et son utilisation en médecine.
Patent EP-0826837-B1 (EP)
Title: Element for sanitary installation
Inventor: STAHLHUT ULRICH
IPC: E03C1/01
Filed: 1997-07-23
Granted: 2001-08-29
Abstract: The module consists of a formed body (1) of insulating material, and contains plumbing components. The body consists of two or more shell elements (2,3), which are adapted to the shape of the components, and are sound-insulating. The elements are fitted together tightly to enclose the components (5). The shell elements are connected especially waterproof to each other via frictionally-engaging tongue-and-groove parts, and may form plumbing components, especially water-containing parts. The formed body consists of several layers of different characteristics, e.g. density, strength, sound absorption, fire-proofing. The front is formed so that it can be tiled.
Patent EP-0808655-B1 (EP)
Inventor: DECKMAN HARRY WILLIAM
IPC: B01J20/18
Filed: 1994-04-25
Granted: 2006-09-13
Abstract: Layers comprising a molecular sieve layer on a porous or non-porous support, having uniform properties and allowing high flux are prepared from colloidal solutions of zeolite or other molecular sieve precursors (particle size less than 100 nm), by deposition, e.g., by spin or dip-coating, or by in situ crystallization.
Patent EP-0835844-B1 (EP)
Inventor: SCHMINKE DIETER
IPC: C02F1/68
Filed: 1997-08-30
Granted: 2002-06-12
Abstract: Apparatus for dosing aqueous H2O2 solutions (active oxygen), especially in water treatment (including disinfection or algae inhibition) in swimming pools, has a measurement- and regulation- device with a through cell (1) producing measurement and reference signal, a control device (5) processing the signals and a dosing device (6) and storage container (9) for the H2O2 solution. The cell (1) has a 3-electrode system producing an electrical signal proportional to the concentration and an electrical reference signal. The system comprises a Pt measuring electrode with a negative reference voltage; an Ag or AgCl reference electrode; and a high-grade steel, Ni or Ti counter-electrode.
Patent EP-0851287-B1 (EP)
Inventor: INABA TADASHI
IPC: G03C5/305
Filed: 1997-12-23
Granted: 2002-03-27
Abstract: There is disclosed a compound represented by the following formula (I): <CHEM> wherein R<1> and R<2> each represent a hydrogen atom, an alkyl group, an aryl group, a heterocyclic group, a carboxyl group, an amino group, an alkoxy group, a sulfo group, a nitro group, a phosphono group, an acylamino group, a sulfonylamino group, an aryloxy group, a sulfamoyl group, a carbamoyl group, an alkylthio group, an arylthio group, an acyl group, a hydroxamic acid group, or a hydroxyl group; R<3> represents a hydrogen atom, an alkyl group substituted with at least one selected from a group consisting of an alkoxy group, an aryl group and a heterocyclic group, an unsubstituted alkyl group, an aryl group, or a heterocyclic group; W represents a divalent linking group having a carbon atom(s); m and n are each an integer of 1 to 3, with the proviso that when n = 1, R<3> does not represent a hydrogen atom, when n = 2 or 3, at least one of nR<3>'s represents an alkyl group, an aryl group, or a heterocyclic group, and when m and n are each 2 or more, mR<1>'s are the same or different and nR<3>'s are the same or different, and M<1>, M<2>, and M<3> each represent a hydrogen atom or a cation. The compound is a chelating agent for various metals that is excellent in biodegradability and metal sequestering capacity.
Patent EP-0834354-B1 (EP)
Inventor: MAIER WILHELM
IPC: B07C3/08
Filed: 1997-09-16
Granted: 2002-05-29
Abstract: The sorted goods (23) are arranged in predetermined sequence in at least two partial rows (22,32). Pick-up elements (12) are moved in succession along a conveyor path past transfer devices (20,30) arranged along the conveyor path, with the number corresponding to the number of partial rows. The pick-up elements move past the transfer devices in a time sequence determined by their transport along the conveyor path to selectively transfer an article. A control device operates the transfer devices in a time sequenced matching the timed sequence of the pick-up elements passing the transfer devices so that the articles of all rows are arranged in the pick-up elements according to the predetermined sequence of rows. Each transfer device has a buffer position.
Patent EP-0832519-B1 (EP)
Inventor: TEN KATE WARNER RUDOLPH THEOPH
IPC: H03M7/30
Filed: 1997-04-02
Granted: 2003-01-29
Abstract: An apparatus for encoding a plurality of n digital information signals is provided with at least a first, second and third input terminal (1,2,3) for receiving a first, a second and a third digital information signal (L,R,C). A matrixing unit (10) is provided for generating a first and a second digital composite signal (L0,R0) from the at least the first, second and third digital information signals. First and second data compression means (22.1,22.2) are provided for data compressing the first and second composite signal (L0,R0) so as to obtain first and second data reduced digital composite signals. A first selection unit (16) is provided for selecting at least one information signal from said plurality of n information signals so as to obtain at least a first auxiliary signal (AUX1). At least a third data compression means (22.3) is present for data compressing the at least first auxiliary signal so as to obtain a first data reduced auxiliary signal. A formatting unit (24) is present for combining the first and second data reduced composite signals and the at least first data reduced auxiliary signal into a transmission signal suitable for transmission via a transmission medium. The apparatus further comprises at least first, second and third masked threshold determining means (26.1,26.3,26.4) for determining first (mtL), second (mtC) and third (mtL0) masked thresholds respectively. A second selection unit (28.1) is provided for deriving one masked threshold from at least the first (mtL) and third (mtL0) masked threshold so as to obtain a first selected masked threshold (mt1). Preferably, said first selected masked threshold is the smallest of the said at least first (mtL) and third (mtL0) masked thresholds.
Patent EP-0928539-B1 (EP)
Inventor: IWAMURA RYUICHI
IPC: H04N5/46
Filed: 1997-09-24
Granted: 2005-09-07
Abstract: A television set includes an integrated receiver decoder. By integrating the receiver/decoder with the television, some circuitry and memory are shared. Moreover, a digital video signal provided by the receiver/decoder need not be converted to an analog NTSC signal before transmission to the television CRT. In one embodiment, where a television having a 16x9 aspect ratio is used, on-screen display data is displayed without distortion.
Patent EP-0934095-B1 (EP)
Inventor: SCHWARTZ ROBERT S
IPC: A61M25/00
Filed: 1997-10-17
Granted: 2004-12-08
Abstract: A hemostasis valve including a collapsible membrane in a portion of a through-lumen. Fluid pressure in a chamber surrounding the collapsible membrane assists in sealing the collapsible membrane around an operating device inserted through the hemostasis valve. Different mechanisms for mechanically deforming the collapsible membrane to assist in sealing are disclosed. Also, a system for continuously flushing a vascular catheter connected to a hemostasis valve at a rate of 0.10 to 10.0 cubic centimeters per minute, and a hemostasis valve assembly including an expandable reservoir which stores liquid volume under pressure.
Patent EP-0879304-B1 (EP)
Inventor: MACIOSSEK ANDREAS
IPC: C25D1/00
Filed: 1997-02-06
Granted: 2000-05-31
Abstract: A three-dimensional formed metallic structure with varying thickness including sloping flanks is formed on a substrate. A conductive layer is applied to the substrate initially, in the form of laterally spaced electrically isolated conductive islands. A cathodic potential is connected to at least one of the islands, leaving others unconnected, and deposition proceeds due to the cathodic potential. As metallic material is deposited and builds up, it eventually contacts adjacent islands, thereby coupling the cathodic potential to a wider area where deposition commences. Deposition is thickest at the at least one island initially coupled to the cathodic potential and thinner progressing away, forming flanks that are linearly sloped, curved or similarly formed by thickness variations the vary proceeding away from the initially coupled island or islands.
Patent EP-0904633-B1 (EP)
Inventor: LEFFEL MICHAEL DAVID
IPC: H03F3/68
Filed: 1997-04-16
Granted: 2006-10-18
Abstract: L'invention concerne un système d'alimentation électrique (500) comprenant un diviseur de puissance (502), une pluralité de modules amplificateurs de puissance (508) réagissant au diviseur de puissance (502), un combinateur de puissance (504) et un contrôleur de passerelle (506). Chaque module amplificateur de puissance (508) comprend un commutateur d'entrée (520), un atténuateur variable (524), un amplificateur R.F. (526) réagissant à l'atténuateur variable (524) et au commutateur d'entrée (520), un commutateur de sortie (530) réagissant à l'amplificateur R.F. (526), et un détecteur d'alarme (532) indiquant un état d'alarme de l'amplificateur R.F. (526). Le combinateur de puissance (504) réagit à la pluralité de modules amplificateurs de puissance (508), et le contrôleur de passerelle (506) est en communication avec chacun desdits modules (508).
Patent EP-0936682-B1 (EP)
Inventor: SHIMIZU YOSHINORI
IPC: H05B33/00
Filed: 1997-07-29
Granted: 2000-08-23
Abstract: A light emitting device comprising: a light emitting component having a gallium nitride compound semiconductor element which has a light emitting layer being capable of emitting blue light, and a garnet phosphor activated with cerium excited by the blue light from said light emitting component and emit yellow light, wherein said light emitting device emit light by blending blue light emitted by the light emitting component and yellow light emitted by the phosphor.
Patent EP-0917674-B1 (EP)
Inventor: KALB ROLAND
IPC: E05F15/70
Filed: 1997-07-30
Granted: 2000-05-03
Abstract: PCT No. PCT/DE97/01668 Sec. 371 Date Jan. 15, 1999 Sec. 102(e) Date Jan. 15, 1999 PCT Filed Jul. 30, 1997 PCT Pub. No. WO98/07079 PCT Pub. Date Feb. 19, 1998A method for controlling a movement of a window pane of a motor vehicle door immediately after the lowering of the window pane, until there is compensation of the system deficiency of the displacement mechanism caused by the displacement of the window pane into the lowering direction of movement. With a short stroke lowering of the upper edge of a free-standing frameless window pane from a keyed sealing engagement on the bodywork side, a signal is generated through opening of the door and passed to an electronics evaluation unit whereupon the drive of the window lifter is activated in the lowering direction until the window pane has moved from its closed position into a predetermined partially opened position. After closing the vehicle door, as a result of the generation of a further signal, the lowered window pane is automatically closed again. During control of the drive for the purpose of automatically lowering the window pane, a first phase of the drive movement is assigned to compensate the system deficiencies of the window lifting mechanism, and a second phase of the movement is assigned to a path of the window lowering.
Patent EP-0929530-B1 (EP)
Inventor: THOMAS ANDREW PETER
IPC: C07D/
Filed: 1997-09-23
Granted: 2002-11-20
Abstract: 4-Anilino-quinazoline derivatives of formula (I) and their salts are new. m = 1 or 2; R1 = H, OH, halo, NO2, CF3, CN, 1-3C alkyl, alkoxy, or alkylthio, or NR5R6; R2 = H, OH, halo, MeO, amino, or NO2; R3 = OH, halo, 1-3C alkyl, alkoxy, or alkanoyloxy, CF3, CN, amino, or NO2; X1 = O, CH2, S, SO, SO2, NR7CO, CONR8, SO2NR9, NR10SO2, or NR11; R5, R6 = H or 1-3C alkyl; R7-R11 = H, 1-3C alkyl, or 1-3C alkoxy(2-3C alkyl); R4 = WR12 (linked through a C atom of R12), WR13, (2-5C alkenylene)-R14, (2-5C alkynylene)-R15, W-X2-W-X3-R16, W-X4-COR22, W-X5-R27, W-X6-W-R33, R39, W-R40, W-R43, or W-R44; when X1 = O, S, SO, or SO2, then R4 can also = 1-3C alkoxy 2-4C alkyl; when X1 = O, then R4 can also = 1-4C alkyl; and provided that, when R4 = W-X2-W-X3-R16, then X1 is not CH2; W = 1-5C alkylene; X2, X3 = as X1, but not CH2; X4 = O or NR23; X5 = OCO, or as X1, but not CH2; X6 = as X1, but not CH2; R12, R14, R15 = Het; Het = 5 or 6 membered saturated heterocyclyl, containing 1 or 2 heteroatoms from O, S, N (optionally containing 1 or 2 substituents G); G = oxo, OH, halo, 1-4C alkyl, alkoxy, or hydroxyalkyl, 1-4C alkanoyl, 2-5C alkoxycarbonyl, carbamoyl, or mono- or di- (1-4C alkyl)carbamoyl; R13 = pyrrolidin-1-yl, imidazolidin-1-yl, or thiomorpholinyl (optionally containing 1 or 2 substituents G); R16 = H or 1-3C alkyl; R22 = NR24R25 or OR26; R23-R26 = as R7; R27, R33 = cyclopentyl, cyclohexyl, or Het (all optionally containing 1 or 2 substituents G), or 1-3C alkyl; provided that, when R27 = 1-3C alkyl, then X5 is a group containing S, and X1 is not CH2; R39 = pyrrolidin-3-yl, piperidin-3-yl, or piperidin-4-yl (all optionally containing 1 or 2 substituents G); R40 = piperazin-1-yl (substituted by 1 or more 1-4C alkanoyl or hydroxyalkyl, 2-5C alkoxycarbonyl, or CONR41R42); R41, R42 = H or 1-4C alkyl; R43 = morpholinyl (optionally containing 1 or 2 substituents G); and R44 = morpholinyl (substituted by at least one, and optionally 2, G); provided that when R4 = alkoxyalkyl or alkyl then R1 and/or R2 = NO2 or \- 1 R3 = 1-3C alkanoyloxy.
Patent EP-1023224-B1 (EP)
Inventor: KRISTIANSSON ANDERS
IPC: A61L2/20
Filed: 1997-09-19
Granted: 2006-01-18
Abstract: In a method of sterilizing containers the container is first sealed and then subjected to electron irradiation. The ozone generated in this way is then retained in the closed container for the purpose of sterilizing the same.
Patent EP-0935560-B1 (EP)
Inventor: SCHIESSL HANS G
IPC: B65C9/04
Filed: 1997-10-06
Granted: 2002-12-18
Abstract: A machine for applying outserts to articles such as bottles has a turntable driven about a vertical axis. A glue roller and an outsert dispenser are positioned in that order of turntable rotation adjacent the periphery of the turntable. A circular array of bottle support assemblies are mounted concentric to the turntable axis. A closed loop cam groove positioned below the turntable surrounds its rotational axis. Cam followers in the groove are connected to mechanisms that drive shafts on which the bottle support assemblies are mounted rotationally in response to turntable rotation. The support assemblies have a bottle holder plate on them in which plate there is a cavity for holding the bottle to which an outsert is to be adhered on a given outside wall area. The wall area is held at constant distance from the glue roller and the foremost outsert in the dispenser for all bottle sizes and shapes by having sets of holder plates in which the bottle cavity is off center by a sufficient amount for said wall area to be at the constant distance from the roller and dispenser.
Patent EP-0954616-B1 (EP)
Inventor: VERDOES DIRK
IPC: B01D9/00
Filed: 1997-12-09
Granted: 2001-07-04
Abstract: In order to separate metals and/or metal alloys of different melting points from one another, a mixture of these metals and/or metal alloys is brought to a temperature at which the metal or the metal alloy of relatively low melting point is molten and the metal or the metal alloy of relatively high melting point is in the solid state. The solid constituents are separated from the melt, use being made of washing column with at least one filter which withstands the temperature of molten metal. Each of the filters is arranged in the wall of a separate pipe which extends through the washing column. The mixture is fed to one end of the washing column and moves along the pipe or pipes, towards means arranged at the opposite side of the washing column for removing solid crystalline material. The melt passes via the filter or filters into the pipe or pipes, and flows in countercurrent to the mixture situated on the outside of the pipe or pipes, towards a melt discharge. A suspension zone situated in an upper part of the washing column changes into a packed bed of crystals. At the bottom of the washing column, the crystals are washed in countercurrent with their own recirculated melt.
Patent EP-0942968-B1 (EP)
Inventor: JAKOBOVITS AYA
IPC: C07K16/00
Filed: 1997-12-03
Granted: 2008-02-27
Abstract: The present invention relates to transgenic non-human animals that are engineered to contain human immunoglobulin gene loci. In particular, animals in accordance with the invention possess human Ig loci that includes plural variable (VH and V kappa ) gene regions. Advantageously, the inclusion of plural variable region genes enhances the specificity and diversity of human antibodies produced by the animal. Further, the inclusion of such regions enhances and reconstitutes B-cell development to the animals, such that the animals possess abundant mature B-cells secreting extremely high affinity antibodies.